These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20327217)

  • 1. The Third International Standard for Corticotrophin and an International Working Standard for Corticotrophin.
    Can Med Assoc J; 1962 Aug; 87(7):358. PubMed ID: 20327217
    [No Abstract]   [Full Text] [Related]  

  • 2. The Third International Standard for Corticotrophin.
    BANGHAM DR; MUSSET MV; STACK-DUNNE MP
    Bull World Health Organ; 1962; 27(3):395-408. PubMed ID: 13966359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Reference Preparation of Tetracosactide for Bioassay: characterization and estimation of its (1-24)corticotrophin-tetracosapeptide content by physicochemical and biological methods.
    Storring PL; Witthaus G; Gaines Das RE; Stamm W
    J Endocrinol; 1984 Jan; 100(1):51-60. PubMed ID: 6317783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Second International Standard for Corticotrophin.
    MUSSETT MV; PERRY WL
    Bull World Health Organ; 1956; 14(3):543-55. PubMed ID: 13342929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation.
    Emanuel RL; Robinson BG; Seely EW; Graves SW; Kohane I; Saltzman D; Barbieri R; Majzoub JA
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):257-62. PubMed ID: 8137526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incompatibility of synthetic tetraicosapeptide corticotrophin with the present USP and International Corticotrophin Standard.
    Rerup C
    Nature; 1966 Jan; 209(5018):89-90. PubMed ID: 4288707
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of the Third International Standard for corticotrophin: accelerated degradation study using different bioassays and isoelectric focusing.
    Storring PL; Gaines-Das RE; Tiplady RJ; Stenning BE; Mistry Y
    J Endocrinol; 1980 Jun; 85(3):533-9. PubMed ID: 6251152
    [No Abstract]   [Full Text] [Related]  

  • 8. Copeptin as a marker of an altered CRH axis in pituitary disease.
    Lewandowski KC; Lewiński A; Skowrońska-Jóźwiak E; Malicka K; Horzelski W; Brabant G
    Endocrine; 2017 Sep; 57(3):474-480. PubMed ID: 28795329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies.
    Perkins AV; Linton EA; Eben F; Simpson J; Wolfe CD; Redman CW
    Br J Obstet Gynaecol; 1995 Feb; 102(2):118-22. PubMed ID: 7756202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus.
    Wang HL; Wayner MJ; Chai CY; Lee EH
    Eur J Neurosci; 1998 Nov; 10(11):3428-37. PubMed ID: 9824456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for cyclic adenosine monophosphate in the synergistic interaction between oxytocin and corticotrophin-releasing factor in isolated human gestational myometrium.
    Quartero HW; Srivatsa G; Gillham B
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):141-5. PubMed ID: 1314722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure.
    Correia ML; Morgan DA; Mitchell JL; Sivitz WI; Mark AL; Haynes WG
    Hypertension; 2001 Sep; 38(3):384-8. PubMed ID: 11566909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of rise in maternal plasma corticotrophin-releasing hormone and its relation to gestational length.
    Leung TN; Chung TK; Madsen G; Lam PK; Sahota D; Smith R
    BJOG; 2001 May; 108(5):527-32. PubMed ID: 11368140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamo-pituitary-adrenocortical function in rats with inherited diabetes insipidus.
    Buckingham JC; Leach JH
    J Physiol; 1980 Aug; 305():397-404. PubMed ID: 6255146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The subcutaneous assay of corticotrophin A. III. A cross-over design using a corticotrophin A standard preparation].
    RERUP C
    Acta Endocrinol (Copenh); 1958 Sep; 29(1):70-82. PubMed ID: 13582532
    [No Abstract]   [Full Text] [Related]  

  • 16. Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence.
    Hibbeln JR; Bissette G; Umhau JC; George DT
    Biol Psychiatry; 2004 Dec; 56(11):895-7. PubMed ID: 15576068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotrophin-Releasing Hormone Stimulates Neurohypophyslal Hormone Release through an Interaction with the Intermediate Lobe of the Pituitary.
    Bondy CA; Gainer H
    J Neuroendocrinol; 1989 Feb; 1(1):5-8. PubMed ID: 19210475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats.
    Reddy DS; Kulkarni SK
    Mol Cell Biochem; 1998 Jun; 183(1-2):25-38. PubMed ID: 9655175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated mid-trimester maternal corticotrophin-releasing hormone levels in pregnancies that delivered before 34 weeks.
    Leung TN; Chung TK; Madsen G; McLean M; Chang AM; Smith R
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1041-6. PubMed ID: 10519429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotrophin-releasing hormone decreases synaptic transmission in rat sensorimotor cortex in vivo.
    Froc DJ; Christie BR
    Neuroscience; 2005; 134(3):965-73. PubMed ID: 16019154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.